Changing the way HIV prevention is delivered – a roadmap
Poverty-targeted cash transfers are reducing some HIV risk behaviours
BCG vaccination causes immune activation of CD4 T-cells in infants
Raltegravir 800mg twice daily appears a good alternative to efavirenz for HIV-TB treatment
Why do surveys show that female sex workers have 14 times the risk of having HIV as other women?
Once-daily elvitegravir works as well as raltegravir at 96 weeks
Cobicistat matches ritonavir as atazanavir booster
Black gay men in the UK almost twice as likely to have HIV as white men, meta-analysis shows
